These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3896138)

  • 1. The potential use of liposome-mediated antiviral therapy.
    Koff WC; Fidler IJ
    Antiviral Res; 1985 Jun; 5(3):179-90. PubMed ID: 3896138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective delivery of drugs encapsulated in liposomes: natural targeting to macrophages involved in various disease states.
    Schroit AJ; Hart IR; Madsen J; Fidler IJ
    J Biol Response Mod; 1983; 2(2):97-100. PubMed ID: 6644336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effect of adriamycin therapy on monocyte activation by liposome-encapsulated immunomodulators.
    Hudson MM; Snyder JS; Jaffe N; Kleinerman ES
    Cancer Res; 1988 Sep; 48(18):5256-63. PubMed ID: 3261632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome targeting to macrophages: opportunities for treatment of infectious diseases.
    Kirsh R; Poste G
    Adv Exp Med Biol; 1986; 202():171-84. PubMed ID: 3538806
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy of disseminated melanoma by liposome-activated macrophages.
    Fidler IJ
    World J Surg; 1992; 16(2):270-6. PubMed ID: 1561809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunomodulators--a new generation of antiviral agents].
    Ershov FI
    Eksp Klin Farmakol; 1995; 58(2):74-8. PubMed ID: 7773099
    [No Abstract]   [Full Text] [Related]  

  • 7. Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines.
    Koff WC; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
    J Leukoc Biol; 1985 Apr; 37(4):461-72. PubMed ID: 3882870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells.
    Düzgüneş N; Pretzer E; Simões S; Slepushkin V; Konopka K; Flasher D; de Lima MC
    Mol Membr Biol; 1999; 16(1):111-8. PubMed ID: 10332745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells.
    Koff WC; Fidler IJ; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
    Science; 1984 Jun; 224(4652):1007-9. PubMed ID: 6426057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery to macrophages for the therapy of cancer and infectious diseases.
    Kirsh R; Bugelski PJ; Poste G
    Ann N Y Acad Sci; 1987; 507():141-54. PubMed ID: 3327409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
    Daemen T; Veninga A; Roerdink FH; Scherphof GL
    Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes.
    Schroit AJ; Madsen J; Nayar R
    Chem Phys Lipids; 1986; 40(2-4):373-93. PubMed ID: 3527460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies between liposomes containing muramyl dipeptide and various immunomodulators on activation of mouse peritoneal macrophages and NK cells.
    Sakita M; Kageyama N; Majima S
    Oncology; 1985; 42(4):259-64. PubMed ID: 4011111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy: current concepts and practices.
    Bean B
    Clin Microbiol Rev; 1992 Apr; 5(2):146-82. PubMed ID: 1576586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes for targeting of antigens and drugs: immunoadjuvant activity and liposome-mediated depletion of macrophages.
    van Rooijen N
    J Drug Target; 2008 Aug; 16(7):529-34. PubMed ID: 18686122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state.
    Sone S; Mutsuura S; Ogawara M; Utsugi T; Tsubura E
    Cancer Immunol Immunother; 1984; 18(3):169-73. PubMed ID: 6568873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral and immunomodulatory activities of ascorbic acid.
    Jariwalla RJ; Harakeh S
    Subcell Biochem; 1996; 25():213-31. PubMed ID: 8821976
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes.
    Szebeni J; Wahl SM; Betageri GV; Wahl LM; Gartner S; Popovic M; Parker RJ; Black CD; Weinstein JN
    AIDS Res Hum Retroviruses; 1990 May; 6(5):691-702. PubMed ID: 2163269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiviral immunological therapeutics].
    de Juan Martín F
    An Esp Pediatr; 1989 Sep; 31 Suppl 38():131-6. PubMed ID: 2484996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.